![]() ![]() ![]() ![]() |
FDA
Home Page | CDRH Home Page | Search
| CDRH
A-Z Index | Contact CDRH
|
![]() |
![]() |
![]() ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness and product labeling for more complete information on this product, its indications for use, and the basis for FDA's approval.
Product Name: TMJ Fossa Eminence Prosthesis™
Manufacturer: TMJ Implants Incorporated
Address: 17301 West Colfax Avenue, Suite 135, Golden,
Colorado 80401
Approval Date: February 27, 2001
Approval Letter: http://www.fda.gov/cdrh/pdf/p000035a.pdf
What is it? The Fossa Eminence device is a metal implant that lines the skull portion (called the glenoid fossa) of the joint that attaches the jaw to the skull (called the temporomandibular joint, or “TMJ”).
How does it work? This device provides a smooth surface for the movement of the jaw as it is opened and closed.
When is it used? This implant is used when moderate to severe pain in the TMJ has not responded to noninvasive therapies such as medication, special appliances worn in the mouth, or physical therapy.
What will it accomplish? The Fossa Eminence is intended to reduce pain and increase the range of motion of the jaw.
When should it not be used? The implant should not be used if there is:
Additional information: Summary of Safety and Effectiveness and labeling are available at: http://www.fda.gov/cdrh/pdf/p000035.html
Updated 4/02/2001
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH